title: [Azilsartan--new representative of the class of angiotensin receptor blockers II].
abstract: The article is a review of published data on the efficacy and tolerability of a new representative of the class of angiotensin receptor blockers II (BRA) azilsartana registered for use in the Russian Federation in 2014. It is found that this drug has the advantage in comparison with several other members of the class BRA (valsartan, olmesartan, candesartan) and an ACE inhibitor ramipril in the form of more powerful antihypertensive effect.
authors.forename: O D
authors.initials: OD
authors.lastname: Ostroumova
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000145:classification / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology*; D057186:Comparative Effectiveness Research; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D010069:Oxadiazoles / Q000494:pharmacology*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D001562:Benzimidazoles; D010069:Oxadiazoles; C521273:azilsartan